Clinical Trials Logo

Gastroesophageal Reflux Disease clinical trials

View clinical trials related to Gastroesophageal Reflux Disease.

Filter by:
  • Temporarily not available  
  • Page 1

NCT ID: NCT02227927 Temporarily not available - Clinical trials for Gastroesophageal Reflux Disease

Treatment Use of Domperidone for Gastroparesis

Start date: n/a
Phase:
Study type: Expanded Access

Domperidone is a drug that may be of benefit to individuals with gastroesophageal reflux disease (GERD), with upper GI symptoms, gastroparesis, and chronic constipation. This is a long-term treatment program for prescription of this drug to all patients who, in the investigators' judgement, could benefit from its use.